Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy T Davis

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Trials|June 9, 2026
Safety and efficacy of intradiscal nucleus pulposus allograft versus sham for lumbar discogenic pain associated with degenerative disc disease: study protocol for a randomized clinical trialTimothy R Deer, Pierce D Nunley, Ramana K Naidu, et al.
Journal of Pain Research|April 14, 2025
Durability of Supplemental Nucleus Pulposus Allograft in Patients with Lumbar Discogenic PainShrif Costandi, Douglas P Beall, Timothy T Davis, et al.
BMC Musculoskeletal Disorders|May 1, 2025
Supplemental nucleus pulposus allograft in patients with lumbar discogenic pain: results of a prospective feasibility studyDouglas P Beall, Timothy T Davis, Kasra Amirdelfan, et al.
Pain Physician|December 2, 2024
Nucleus Pulposus Allograft Supplementation in Patients with Lumbar Discogenic Pain: Initial 6-month Outcomes from a Prospective Clinical Pilot StudyDouglas P Beall, Timothy T Davis, Kasra Amirdelfan, et al.
International Journal of Spine Surgery|June 26, 2024
Allogeneic Disc Progenitor Cells Safely Increase Disc Volume and Improve Pain, Disability, and Quality of Life in Patients With Lumbar Disc Degeneration-Results of an FDA-Approved Biologic Therapy Randomized Clinical TrialMatthew F Gornet, Douglas P Beall, Timothy T Davis, et al.
Journal of Pain Research|July 8, 2025
A Proposed Diagnostic and Treatment Algorithm for the Management of Lumbar Discogenic PainMorgan P Lorio, Douglas P Beall, Thomas J Myers, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 2, 2025
Efficacy and safety of allogeneic mesenchymal precursor cells with and without hyaluronic acid for treatment of chronic low back pain: A prospective, randomized, double blind, concurrent-controlled 36-month studyDouglas P Beall, Hyun W Bae, Michael J DePalma, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 12, 2014
Use of a newly developed delivery device for percutaneous introduction of multiple lead configurations for spinal cord stimulationLouis J Raso, Timothy R Deer, Sandford M Schocket, et al.
Journal of Pain Research|December 19, 2025
A Primer on Anatomy, Biophysics, Pathology, Imaging and Treatment of the Intervertebral Disc and the Anterior Spinal Column: The Discogenic, Intervertebral, Spinal Column (DISC) ASPN WorkgroupJay S Grider, Timothy R Deer, Douglas P Beall, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Trials|June 9, 2026
Safety and efficacy of intradiscal nucleus pulposus allograft versus sham for lumbar discogenic pain associated with degenerative disc disease: study protocol for a randomized clinical trialTimothy R Deer, Pierce D Nunley, Ramana K Naidu, et al.
Journal of Pain Research|April 14, 2025
Durability of Supplemental Nucleus Pulposus Allograft in Patients with Lumbar Discogenic PainShrif Costandi, Douglas P Beall, Timothy T Davis, et al.
BMC Musculoskeletal Disorders|May 1, 2025
Supplemental nucleus pulposus allograft in patients with lumbar discogenic pain: results of a prospective feasibility studyDouglas P Beall, Timothy T Davis, Kasra Amirdelfan, et al.
Pain Physician|December 2, 2024
Nucleus Pulposus Allograft Supplementation in Patients with Lumbar Discogenic Pain: Initial 6-month Outcomes from a Prospective Clinical Pilot StudyDouglas P Beall, Timothy T Davis, Kasra Amirdelfan, et al.
International Journal of Spine Surgery|June 26, 2024
Allogeneic Disc Progenitor Cells Safely Increase Disc Volume and Improve Pain, Disability, and Quality of Life in Patients With Lumbar Disc Degeneration-Results of an FDA-Approved Biologic Therapy Randomized Clinical TrialMatthew F Gornet, Douglas P Beall, Timothy T Davis, et al.
Journal of Pain Research|July 8, 2025
A Proposed Diagnostic and Treatment Algorithm for the Management of Lumbar Discogenic PainMorgan P Lorio, Douglas P Beall, Thomas J Myers, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 2, 2025
Efficacy and safety of allogeneic mesenchymal precursor cells with and without hyaluronic acid for treatment of chronic low back pain: A prospective, randomized, double blind, concurrent-controlled 36-month studyDouglas P Beall, Hyun W Bae, Michael J DePalma, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 12, 2014
Use of a newly developed delivery device for percutaneous introduction of multiple lead configurations for spinal cord stimulationLouis J Raso, Timothy R Deer, Sandford M Schocket, et al.
Journal of Pain Research|December 19, 2025
A Primer on Anatomy, Biophysics, Pathology, Imaging and Treatment of the Intervertebral Disc and the Anterior Spinal Column: The Discogenic, Intervertebral, Spinal Column (DISC) ASPN WorkgroupJay S Grider, Timothy R Deer, Douglas P Beall, et al.
Pageof 2